rs11568345
Positions:
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1
The NM_014585.6(SLC40A1):c.327C>T(p.Ile109Ile) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00415 in 1,613,972 control chromosomes in the GnomAD database, including 254 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.023 ( 133 hom., cov: 32)
Exomes 𝑓: 0.0022 ( 121 hom. )
Consequence
SLC40A1
NM_014585.6 synonymous
NM_014585.6 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.510
Genes affected
SLC40A1 (HGNC:10909): (solute carrier family 40 member 1) The protein encoded by this gene is a cell membrane protein that may be involved in iron export from duodenal epithelial cells. Defects in this gene are a cause of hemochromatosis type 4 (HFE4). [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.35).
BP6
Variant 2-189572906-G-A is Benign according to our data. Variant chr2-189572906-G-A is described in ClinVar as [Benign]. Clinvar id is 333171.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.51 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0771 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC40A1 | NM_014585.6 | c.327C>T | p.Ile109Ile | synonymous_variant | 4/8 | ENST00000261024.7 | NP_055400.1 | |
SLC40A1 | XM_047444066.1 | c.207C>T | p.Ile69Ile | synonymous_variant | 4/8 | XP_047300022.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC40A1 | ENST00000261024.7 | c.327C>T | p.Ile109Ile | synonymous_variant | 4/8 | 1 | NM_014585.6 | ENSP00000261024.3 | ||
SLC40A1 | ENST00000479598.5 | n.608C>T | non_coding_transcript_exon_variant | 4/4 | 1 | |||||
SLC40A1 | ENST00000427241.5 | c.327C>T | p.Ile109Ile | synonymous_variant | 6/8 | 5 | ENSP00000390005.1 |
Frequencies
GnomAD3 genomes AF: 0.0228 AC: 3474AN: 152142Hom.: 133 Cov.: 32
GnomAD3 genomes
AF:
AC:
3474
AN:
152142
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00596 AC: 1499AN: 251378Hom.: 55 AF XY: 0.00439 AC XY: 597AN XY: 135858
GnomAD3 exomes
AF:
AC:
1499
AN:
251378
Hom.:
AF XY:
AC XY:
597
AN XY:
135858
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00220 AC: 3222AN: 1461712Hom.: 121 Cov.: 31 AF XY: 0.00187 AC XY: 1360AN XY: 727160
GnomAD4 exome
AF:
AC:
3222
AN:
1461712
Hom.:
Cov.:
31
AF XY:
AC XY:
1360
AN XY:
727160
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0229 AC: 3480AN: 152260Hom.: 133 Cov.: 32 AF XY: 0.0217 AC XY: 1619AN XY: 74462
GnomAD4 genome
AF:
AC:
3480
AN:
152260
Hom.:
Cov.:
32
AF XY:
AC XY:
1619
AN XY:
74462
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
12
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Hemochromatosis type 4 Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign. - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at